IUD may greatly reduce the risk of cervical cancer

Share This Post

One of the longest-lasting female contraceptive methods and one of the best methods may provide unexpected health benefits for women using this method.

A new analysis of intrauterine devices (IUDs) found that women who used the contraceptive method were significantly less likely to develop cervical cancer, and the IUD reduced the incidence of cancer by about a third. Victoria Cortessis, an expert in preventive medicine at the University of Southern California, said: “The patterns we found are amazing, not at all so subtle. While making contraception decisions, the possibility that women may experience some cancer control help may be very influential.

Cortessis and researchers reviewed the data of 16 observational studies, these studies monitored more than 12,000 women to determine the participants to use the incidence of IUD and cervical cancer, cervical cancer is the fourth most common women’s cancer in the world. They found that 36% of women who participated in the study used IUDs than women who did not use it. Of course, such meta-analysis is essentially observational-neither new studies nor studies show any kind of causal effect.

However, the researchers say that this is an amazing and unexpected result that definitely needs further investigation. Cortez told “Real-Time Science”: “It looks real.””To truly believe, we need to go back to do research and find a mechanism.”

No one is sure what the mechanism is, but the research team speculates that the placement of the IUD may stimulate the immune response of the cervix, causing the body to protect itself from any existing human papillomavirus (HPV) infections- Causes more than 70% of all cervical cancer cases.

“The data shows that the presence of the IUD in the uterus stimulates the immune response, which severely damages the sperm and prevents the sperm from reaching the egg.” Cortessis explained to HealthDay.”IUD may affect other immune phenomena.”Another hypothesis is that when the IUD is removed from the body, the scraping effect can simultaneously remove the infected cells, which may help reduce the risk of cancer tissue development.

No matter what happens to reduce the risk of cancer, the huge size of the gap shown in the data means that this is what health researchers want to study.”If this is not a real phenomenon, I would be shocked,” Cortsis told Time Weekly.”We need to figure out what happened and make some fine-tuning to see what uses can prevent cervical cancer and combine it with contraception counseling.”

The researchers are keen to emphasize that their findings should not be regarded as a recommendation that women should use an IUD to reduce the chance of cervical cancer.The best way is to regularly screen for cervical cancer and get HPV vaccine.”Screening is everything,” Corteses told Newsweek.

“If a woman has a lifetime screening interview, her risk is much lower.”

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma
CAR T-Cell therapy

Targeting FGFR4 and CD276 with CAR T-cells demonstrates a strong antitumor impact against children rhabdomyosarcoma

Chimeric antigen receptor (CAR) T-cells that specifically target Fibroblast Growth Factor Receptor 4 (FGFR4), a surface tyrosine receptor that is extensively expressed in rhabdomyosarcoma (RMS), are now undergoing clinical research. However, the effectiveness of these CAR T-cells may be hindered by tumor heterogeneity and inadequate activation. In this study, we present a method to enhance the co-stimulatory and targeting characteristics of a FGFR4 CAR through an optimization process. We substituted the hinge and transmembrane domain of CD8 as well as the 4-1BB co-stimulatory domain with the corresponding domains of CD28. The CARs produced exhibit heightened anti-tumor efficacy in multiple RMS xenograft models, with the exception of the RMS559 cell line, which is known for its aggressive nature.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy